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Scenarios (Proportion developing OA Number of new OA cases likely Number of new OA cases likely Proportion of all new cases
after arthroscopic surgery) due to arthroscopic surgery due to arthroscopic surgery aged 5-54 “due to” arthroscopy
(5-54 years) (all ages) (proportion of new cases - all ages)
10% 2265 6267 1.9% (1.4%)
20% 4531 12534 3.9% (2.9%)
30% 6796 18801 5.8% (4.3%)
40% 9062 25068 7.8% (5.8%)
OA over time, and a linear risk of developing OA after having arthroscopic
surgery.
Results: Examination of arthroscopic rates showed no signiﬁcant ﬂuctu-
ation from 2000 to 2007. Overall, the rate of arthroscopic knee surgery
was 188 per 100,000 population in Ontario, 127 per 100,000 for ages 5-44
years. Men aged 5 to 44 years had twice as many surgeries as women
the same age (166/100,000 persons and 88/100,000 persons respectively).
Rates increased with increasing age peaking in the 45-54 years age group
in men and in the 54-64 years age group in women. The ﬁndings from
applying the rates for those aged 5 to 44 years at surgery to the population
and the four scenarios for the proportion developing OA over 10 years are
shown in the table below.
Conclusions: A calculation juxtaposing different sources of data suggests
that arthroscopic surgery associated with knee injury likely accounts for
between 1.9% and 7.8% of new cases of OA in the younger population and
between 1.4% and 5.8% of all cases. Given population rates of arthroscopic
surgery and assuming outcomes similar to those reported in the literature,
this simple estimation highlights the importance of injury prevention
particularly in relation to OA in the younger population.
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EROSIVE HAND OSTEOARTHRITIS: ITS PREVALENCE AND CLINICAL
IMPACT IN THE GENERAL POPULATION AND SYMPTOMATIC HAND
OSTEOARTHRITIS
W.-Y. Kwok1, M. Kloppenburg1, F.R. Rosendaal2, J.B. van Meurs3,
A. Hofman4, S.M. Bierma-Zeinstra5
1Leiden Univ. Med. Ctr., Dept. of Rheumatology, Leiden, Netherlands; 2Leiden
Univ. Med. Ctr., Dept. of Clinical Epidemiology, Leiden, Netherlands; 3Erasmus
Med. Ctr., Dept. of Internal Med., Rotterdam, Netherlands; 4Erasmus Med. Ctr.,
Dept. of Epidemiology, Rotterdam, Netherlands; 5Erasmus Med. Ctr., Dept. of
Gen. Practice, Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) is a heterogeneous disease that is prevalent
in hands. Different subsets within hand OA, such as nodular hand OA and
erosive hand OA (EOA), are recognized. EOA is a subset, deﬁned as having
erosions in interphalangeal joints on radiographs, that is suggested to have
an aggressive clinical course. No clear data about prevalence and clinical
burden of EOA are available. This study assesses the prevalences of erosive
hand OA in the general population and symptomatic hand OA, and its
relation to hand pain and disability.
Methods: Cross-sectional data of participants from a population based
study (age ≥ 55 years) in the Rotterdam area were used. Radiographs of
the hands were scored previously by the Kellgren-Lawrence (K/L) scoring
method. In the present study, erosive lesions (deﬁned as an erosive or
remodeled phase) in the distal, proximal and thumb interphalangeal joints
(DIPJs, PIPJs and IPJs) were scored according by the Verbruggen-Veys
scoring method. Radiographic hand OA was deﬁned as the presence of K/L
grade ≥ 2 in two out of three groups of hand joints (DIPJs/IPJs, PIPJs and
ﬁrst carpometacarpal joint (1st CMCJs)) of each hand. Symptomatic hand
OA was deﬁned as hand pain and presence of criteria for radiographic hand
OA. Hand pain was assessed by a standard question by trained interviewers.
Hand disability was measured by 8 hand questions in the Stanford Health
Assessment Questionnaire (HAQ). A mean HAQ-score of ≥ 0.5 was classiﬁed
as disability.
Point prevalence was calculated as to divide the number of subjects with
one erosive lesion by the total population. Multivariate logistic regression
analyses were used to estimate the effect of erosive hand OA on pain
and disability between erosive and non-erosive patients. Results were
presented as odds ratios (OR) with a 95% conﬁdence interval (95%CI),
adjusted for age and sex.
Results: Of the 3459 participants, 56% was female, with a mean age (SD)
of 66 years (7.0) and mean Body Mass Index (SD) of 26.3 (3.6) kg/m2.
Radiographic hand OA was seen in 27% (n=941) and symptomatic hand
OA in 6% (n=207). One erosion only was seen in 96 subjects and minimal
two erosions or more were seen in 44 persons (46% of erosive patients).
The overall prevalence of EOA in the general population was 2.8% and in
individuals with symptomatic hand OA 15.8%. Presence of erosive hand OA
led to an adjusted OR for pain of 3.6 (95%CI 2.4-5.6) and for disability 2.4
(95% CI 1.1-5.4) in the general population.
In subjects with radiographic hand OA, participants with erosion were
more likely to experience hand pain (adjusted OR 3.1, 95%CI 1.9-5.2) and
more likely to report hand disability (adjusted OR 3.1, 95%CI 1.3-7.6). A
dose-response relationship between the number of erosions per participant
and presence of pain was seen. If participants had two or more joints with
erosions, they were ﬁve times more likely to have pain in their hands than
individuals without erosions in the general population (adjusted OR 5.3,
95%CI 2.9-9.9).
Conclusions: The prevalence of erosive hand osteoarthritis is 2.8% in the
general population and rises to 15.8% in individuals with symptomatic
hand OA. It has a substantial impact on clinical burden. Further studies
should focus on treatment options for this hand OA subset.
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ALL-CAUSE AND DISEASE-SPECIFIC MORTALITY IN PATIENTS WITH KNEE
OR HIP OSTEOARTHRITIS: POPULATION-BASED COHORT STUDY
E. Nüesch1, P. Dieppe2, S. Reichenbach1, S. Iff1, P. Jüni1
1Univ. of Bern, Bern, Switzerland; 2Peninsula Coll. of Med. and Dentistry,
Plymouth, United Kingdom
Purpose: Older age, presence of comorbidities and adverse effects of anal-
gesics have been suggested to contribute to an excess mortality in patients
with osteoarthritis, but available data are limited. Therefore, we examined
determinants of mortality in a large population based cohort of patients
with osteoarthritis of the knee or hip.
Methods: We analysed all-cause and disease-speciﬁc mortality over a
median of 14 years in 1163 patients with symptomatic and radiologically
conﬁrmed osteoarthritis of the knee or hip from the population-based
Somerset and Avon Survey of Health (SASH) using mortality data from
Characteristic Hazard ratio P-value
(95% conﬁdence interval)
Age at baseline <0.001
35 to 54 years 1.00 (reference)
55 to 74 years 12.1 (5.38 to 27.4)
≥75 years 40.7 (17.7 to 93.5)
Male gender 1.56 (1.27 to 1.90) <0.001
Lower social class 1.13 (0.93 to 1.38) 0.21
Smoking at baseline 1.26 (0.97 to 1.63) 0.08
Type of osteoarthritis 0.66
Knee only 1.00 (reference)
Hip only 1.12 (0.87 to 1.45)
Knee and hip 1.08 (0.86 to 1.35)
Previous joint replacement 1.16 (0.83 to 1.61) 0.38
Obesity 0.84 (0.67 to 1.05) 0.13
COPD 1.20 (0.93 to 1.55) 0.16
Diabetes 1.97 (1.33 to 2.93) 0.001
Depression 0.95 (0.68 to 1.34) 0.79
Arterial hypertension 1.14 (0.92 to 1.40) 0.24
Cancer 2.32 (1.53 to 3.52) <0.001
Chronic inﬂammatory disease 1.01 (0.83 to 1.24) 0.91
Eye disease 1.07 (0.81 to 1.42) 0.65
Cardiovascular disease 1.40 (1.14 to 1.73) 0.002
Knee or hip pain 0.90 (0.73 to 1.10) 0.30
Walking disability 1.53 (1.23 to 1.91) <0.001
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the Oﬃce of National Statistics. Age- and gender standardised mortality
rates were compared to the general population for all-cause mortality
and disease-speciﬁc mortality (cardiovascular, cancer-related, respiratory,
gastrointestinal and dementia-associated death). Multi-variable Cox re-
gression models including demographic and socioeconomic characteristics,
self-report comorbidity, hip or knee pain and disability were used to
determine whether these characteristics were associated with increased
mortality. Multiple imputation was used to address missing covariate data.
Results: We found an excess all-cause mortality in osteoarthritis patients
compared to the general population with an SMR of 1.55 (95% CI 1.41 to
1.70). Excess mortality was observed for all disease-speciﬁc mortalities, but
was particularly pronounced for cardiovascular (SMR 1.71, 95% CI 1.49 to
1.98) and dementia-associated mortality (SMR 1.99, 95% CI 1.22 to 3.25).
The Table presents multivariable hazard ratios for the association of dif-
ferent baseline characteristics with all-cause mortality. Increased mortality
was found with older age, male gender, self-reported history of diabetes,
cancer or cardiovascular disease, and walking disability (P≤0.002), but not
with previous joint replacement, obesity, depression, chronic inﬂammatory
disease, eye disease and presence of pain at baseline.
Conclusions: Osteoarthritis patients are at higher risk of death for any
cause than the general population, which is particularly pronounced for
cardiovascular and dementia-associated mortality. A history of diabetes,
cancer or cardiovascular disease and the presence of walking disability at
baseline increase the risk of all-cause mortality.
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OARSI RECOMMENDATIONS FOR THE MANAGEMENT OF HIP AND KNEE
OSTEOARTHRITIS: WHICH TREATMENTS ARE BEING USED? AUDIT OF
PATIENTS COMING TO ARTHROPLASTY IN SCOTLAND
C. Beadle, C.R. Howie, G. Nuki
Univ. of Edinburgh, Edinburgh, United Kingdom
Purpose: The Osteoarthritis Research Society International (OARSI) has
recently published 25 recommendations for the treatment of OA of the hip
and knee following a critical appraisal of existing guidelines, identiﬁcation
of a core set of recommendations, and a systematic review of the evidence
for relevant therapies. The purpose of this study was to audit current
practice in Scotland for non-pharmacological (NP) and pharmacological (P)
treatments in patients with OA hip or knee awaiting arthroplasty against
the OARSI recommendations.
Methods: Patients with OA hip or knee awaiting arthroplasty in 2009/10
were interviewed by an experienced musculoskeletal nurse in an Or-
thopaedic Outpatient setting. Demographic data, duration of symptoms
and comorbidities were recorded. Standardised questions relating to 20
audit criteria were based on the OARSI recommendations for NP and P
treatments. Information obtained was recorded using an audit support
tool adapted from the National Institute for Health and Clinical Excellence
(NICE).
Results: 200 Caucasian patients (87 male, 113 female), mean age 67 years
(range 36-91) were interviewed. 110 had hip OA and 90 knee OA. The
duration of symptoms prior to elective arthroplasty was 6 (range 0.5-39)
years for hip OA and 9 (0.5-50) years for knee OA. Most patients were
overweight, BMI >25 in 73% of those with hip OA and 80% knee OA;
and many were obese, BMI >30 in 33% of hip OA and 53% of knee OA
patients. Most (70% hip OA, 78% knee OA) had received a combination of P
and NP therapies but written information about the objectives of therapy
and the need for lifestyle modiﬁcations had been given to less than half.
Only 43% of patients with a BMI >25 had ever been encouraged to lose
weight, and only 20% maintained weight loss. Advice to exercise had been
given to 67% of patients and 61% had been referred to a physiotherapist
for assessment and instruction in appropriate exercises. While 90% had
been instructed in muscle strengthening exercises, 84% in range of motion
exercises and 56% were given pool exercises; advice about aerobic ﬁtness
exercise was given to only 31% and advice on appropriate footwear to only
23%. Ambulatory aids were used by 30% of patients but other NP modalities
of therapy were seldom employed: thermal treatments 26%, acupuncture
15%, TENS 6%, shoe insoles 9%, knee braces 2% and regular telephone
contact in 3%. Patients > 75 years of age were referred to a physical
therapist less frequently (46%) and used NP modalities of treatment less
often. All patients had used analgesic drugs but acetaminophen was the
initial choice in only 55% and 81% had used preparations containing weak
opioids. Oral NSAIDs were taken by 64% of patients, in 43% without gastric
protection, and 33% had experienced upper GI symptoms. Selective COX-2
inhibitors were only used by 5% of patients. Topical NSAIDs were employed
by 31% of patients, more often as an adjunct than as an alternative to
oral medication. Capsaicin was used by 4% of patients. Nutraceuticals were
taken by 40% of patients, either as glucosamine sulphate alone (24%) or
in combination with chondroitin sulphate. 19% of patients with knee OA
had had at least one intra-articular (IA) corticosteroid injection and 5% had
undergone joint lavage, but IA hyaluronate injections were not used.
Conclusions: In many patients with OA hip and knee coming to arthro-
plasty in Scotland OARSI recommendations for P, and particularly NP
treatment, have never been implemented. The audit suggests that there
is a need for dissemination of the guidelines, for the development of
standards of care and especially for overcoming barriers to provision of
core therapies.
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RISK FACTORS AND SYMPTOMS OF RADIOLOGICAL KNEE
OSTEOARTHRITIS: DOES BMI MAKE A DIFFERENCE?
B.M. de Klerk, D. Schiphof, B.W. Koes, S.M. Bierma-Zeinstra
Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: Being overweight is a known risk factor for osteoarthritis (OA).
Whether there are differences in risk factors for, and symptoms of, OA
between overweight people and normal weight people is not yet known.
We aim to identify which risk factors and symptoms are associated with
the prevalence of radiological knee OA (ROA, Kellgren & Lawrence score≥2)
in people with high BMI (≥27) and in people with normal BMI (<27) and if
these differ between the two groups.
Methods: Data of the RS-III-1 cohort of the Rotterdam study was used
(a population based cohort study). Eligible participants were aged 45-60
years and had an available knee X-ray. In total 1242 people with normal
BMI (mean age 54.4, 59.7% females) and 1224 with high BMI (mean age
54.8, 53.0% females) were included. Univariate logistic regression analysis
was used to test potential risk factors for knee ROA in people with high
vs. normal BMI. Symptoms and female hormonal speciﬁc risk factors were
tested in women only.
Tested potential risk factors were: age, gender, BMI, hip ROA, knee trauma,
diabetes, and varus alignment in one or both knees. In women-only addi-
tional risk factors were tested: menopausal (MP-) status, age at menarche
≥ 12 years, waist-hip ratio, and Heberden nodes (HN). Tested symptoms
were: WOMAC pain score, knee morning stiffness, limited extension (vs.
normal/hyper), and pain on palpation.
Risk factors and symptoms differing in statistical signiﬁcance between the
groups were tested for interaction with BMI using multivariate logistic
regression analysis. All outcomes were adjusted for age and BMI.
Results: Knee ROA was present in 5.8% in the normal BMI group and 9.0%
in the high BMI group.
In people with normal BMI the statistically signiﬁcant risk factors were:
age (Odds Ratio=1.08), and BMI (OR=1.16). In women-only these were:
MP-status (OR=3.98), and age at menarche (OR=0.39). The only statistically
signiﬁcant symptom was limited extension (OR=2.44).
Statistically signiﬁcant risk factors in the high-BMI group were: age
(OR=1.08), BMI (OR=1.13), and knee trauma (OR=1.61). In women-only this
was HN (OR=2.19). Statistically signiﬁcant symptoms were: WOMAC pain
(OR=5.14), morning stiffness (OR=4.67), and limited extension (OR=2.65).
Differences between the normal BMI group vs. the high BMI group in
signiﬁcant relationships were seen in the following risk factors: knee
trauma (BMI<27 OR=1.27 vs. BMI≥27 OR=1.61), MP-status (3.98 vs. 1.31),
age at menarche (0.39 vs. 0.59), and HN (1.65 vs. 2.19). For symptoms
differences in signiﬁcant relationships were seen in: WOMAC pain (2.52 vs.
5.14), morning stiffness (1.90 vs. 4.67), and limited extension (2.44 vs. 2.65.
All risk factors and symptoms that differ in statistical signiﬁcance were
formally tested for interaction with BMI; none of the interactions were
statistically signiﬁcant.
Conclusions: Risk factors for, and symptoms of, knee ROA do differ be-
tween people with normal vs. high BMI. There are strong indications that:
1) in overweight women morning stiffness is much stronger related to
having knee ROA than in non-overweight women and 2) in non-overweight
women is being post-menopausal related to having knee ROA, but not in
overweight women.
